[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 257-262

Título :	Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study
Tipo de documento:	texto impreso
Autores:	Kenneth Kobak, Autor ; John H. Greist, Autor ; James W. Jefferson, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 257-262
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Fluoxetina, Trastornos fóbicos, Inhibidores selectivos de la recaptación de serotonina.
Resumen:	The objective of the study was to examine the efficacy of fluoxetine in social phobia. Sixty subjects were randomly assigned to 14 weeks of double-blind therapy with either fluoxetine or placebo. Dose was fixed at 20 mg for fluoxetine during the first 8 weeks of double-blind treatment; during the final 6 weeks, the dose could be increased every two weeks by 20 mg to a maximum of 60 mg/day. An intentto-treat analysis was used.
Link:	./index.php?lvl=notice_display&id=31064

[artículo] Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study [texto impreso] / Kenneth Kobak, Autor ; John H. Greist, Autor ; James W. Jefferson, Autor . - 2023 . - pp. 257-262.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 257-262

Palabras clave:	Fluoxetina, Trastornos fóbicos, Inhibidores selectivos de la recaptación de serotonina.
Resumen:	The objective of the study was to examine the efficacy of fluoxetine in social phobia. Sixty subjects were randomly assigned to 14 weeks of double-blind therapy with either fluoxetine or placebo. Dose was fixed at 20 mg for fluoxetine during the first 8 weeks of double-blind treatment; during the final 6 weeks, the dose could be increased every two weeks by 20 mg to a maximum of 60 mg/day. An intentto-treat analysis was used.
Link:	./index.php?lvl=notice_display&id=31064